Home LiteratureArticle Details
PMID: 12417558 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions.

The Journal of clinical investigation ·Vol. 110 ·No. 9 ·2002-11-00 ·Pages 1221-32

Horwich A

Abstract

暂无摘要

MeSH Terms
Amyloid/biosynthesis,chemistry Animals Humans Molecular Chaperones/chemistry Mutation Protein Biosynthesis Protein Folding Thermodynamics
Chemicals
Amyloid Molecular Chaperones
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Horwich Arthur
Howard Hughes Medical Institute and Department Of Genetics, Yale University School Of Medicine, New Haven, Connecticut 06510, USA. horwich@csb.yale.edu
References (74)
74 references, click to expand
  1. The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex.
    Nature. 1997 Aug 21;388(6644):741-50 PMID: 9285585
  2. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    Science. 1997 Sep 26;277(5334):1990-3 PMID: 9302293
  3. Domain swapping: entangling alliances between proteins.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3127-31 PMID: 8159715
  4. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5355-8 PMID: 8202492
  5. A role for destabilizing amino acid replacements in light-chain amyloidosis.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5446-50 PMID: 8202506
  6. Crystal structure of P22 tailspike protein: interdigitated subunits in a thermostable trimer.
    Science. 1994 Jul 15;265(5170):383-6 PMID: 8023158
  7. The crystal structure of the bacterial chaperonin GroEL at 2.8 A.
    Nature. 1994 Oct 13;371(6498):578-86 PMID: 7935790
  8. Selective in vivo rescue by GroEL/ES of thermolabile folding intermediates to phage P22 structural proteins.
    J Biol Chem. 1994 Nov 11;269(45):27941-51 PMID: 7961726
  9. Protein disaggregation mediated by heat-shock protein Hsp104.
    Nature. 1994 Dec 1;372(6505):475-8 PMID: 7984243
  10. Characterizing transition states in protein folding: an essential step in the puzzle.
    Curr Opin Struct Biol. 1995 Feb;5(1):79-84 PMID: 7773750
  11. The Hsp70 and Hsp60 chaperone machines.
    Cell. 1998 Feb 6;92(3):351-66 PMID: 9476895
  12. Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition.
    Nat Biotechnol. 1996 Oct;14(10):1283-7 PMID: 9631094
  13. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins.
    Cell. 1998 Jul 10;94(1):73-82 PMID: 9674429
  14. Familial mutations and the thermodynamic stability of the recombinant human prion protein.
    J Biol Chem. 1998 Nov 20;273(47):31048-52 PMID: 9813003
  15. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing.
    EMBO J. 1999 Feb 15;18(4):815-21 PMID: 10022824
  16. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Biochemistry. 1999 Mar 16;38(11):3258-67 PMID: 10079068
  17. Protein misfolding, evolution and disease.
    Trends Biochem Sci. 1999 Sep;24(9):329-32 PMID: 10470028
  18. Formation of short-lived protein aggregates directly from the coil in two-state folding.
    Biochemistry. 1999 Oct 5;38(40):13006-12 PMID: 10529170
  19. Reconstitution of active dimeric ribulose bisphosphate carboxylase from an unfoleded state depends on two chaperonin proteins and Mg-ATP.
    Nature. 1989 Dec 21-28;342(6252):884-9 PMID: 10532860
  20. Electron microscopic observations on a fibrous component in amyloid of diverse origins.
    Nature. 1959 Apr 25;183(4669):1202-3 PMID: 13657054
  21. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Biochemistry. 2000 Mar 14;39(10):2552-63 PMID: 10704204
  22. Rational design of potent human transthyretin amyloid disease inhibitors.
    Nat Struct Biol. 2000 Apr;7(4):312-21 PMID: 10742177
  23. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.
    Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4897-902 PMID: 10781096
  24. A surprising simplicity to protein folding.
    Nature. 2000 May 4;405(6782):39-42 PMID: 10811210
  25. A glimpse of a possible amyloidogenic intermediate of transthyretin.
    Nat Struct Biol. 2000 Sep;7(9):754-7 PMID: 10966644
  26. Biochemical basis of oxidative protein folding in the endoplasmic reticulum.
    Science. 2000 Nov 24;290(5496):1571-4 PMID: 11090354
  27. Mechanisms of protein folding.
    Curr Opin Struct Biol. 2001 Feb;11(1):70-82 PMID: 11179895
  28. Amyloid fibrils from muscle myoglobin.
    Nature. 2001 Mar 8;410(6825):165-6 PMID: 11242064
  29. Intracellular functions of N-linked glycans.
    Science. 2001 Mar 23;291(5512):2364-9 PMID: 11269317
  30. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin.
    Cell. 2001 Mar 23;104(6):937-48 PMID: 11290330
  31. Shattuck lecture--neurodegenerative diseases and prions.
    N Engl J Med. 2001 May 17;344(20):1516-26 PMID: 11357156
  32. Impairment of the ubiquitin-proteasome system by protein aggregation.
    Science. 2001 May 25;292(5521):1552-5 PMID: 11375494
  33. Folding of prion protein to its native alpha-helical conformation is under kinetic control.
    J Biol Chem. 2001 Jun 8;276(23):19687-90 PMID: 11306559
  34. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.
    Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9836-41 PMID: 11504948
  35. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.
    Biochemistry. 2001 Sep 25;40(38):11442-52 PMID: 11560492
  36. Trans-suppression of misfolding in an amyloid disease.
    Science. 2001 Sep 28;293(5539):2459-62 PMID: 11577236
  37. The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.
    Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14943-8 PMID: 11752443
  38. Kinetic partitioning of protein folding and aggregation.
    Nat Struct Biol. 2002 Feb;9(2):137-43 PMID: 11799398
  39. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.
    Nature. 2002 Apr 4;416(6880):507-11 PMID: 11932737
  40. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
    Nature. 2002 Apr 4;416(6880):535-9 PMID: 11932745
  41. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.
    J Clin Invest. 2002 Nov;110(10):1375-81 PMID: 12438432
  42. Orchestrating the unfolded protein response in health and disease.
    J Clin Invest. 2002 Nov;110(10):1389-98 PMID: 12438434
  43. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.
    J Clin Invest. 2002 Dec;110(11):1585-90 PMID: 12464660
  44. High-resolution electron microscopic analysis of the amyloid fibril.
    J Cell Biol. 1967 Jun;33(3):679-708 PMID: 6036530
  45. X-ray diffraction studies on amyloid filaments.
    J Histochem Cytochem. 1968 Nov;16(11):673-7 PMID: 5723775
  46. Characterization of the amyloid fibril as a cross-beta protein.
    Proc Soc Exp Biol Med. 1969 Sep;131(4):1373-5 PMID: 5812002
  47. An amyloid protein: the amino-terminal variable fragment of an immunoglobulin light chain.
    Biochem Biophys Res Commun. 1970 Dec 9;41(5):1287-9 PMID: 4099001
  48. Principles that govern the folding of protein chains.
    Science. 1973 Jul 20;181(4096):223-30 PMID: 4124164
  49. Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers.
    Eur J Biochem. 1974 Sep 1;47(2):409-15 PMID: 4607014
  50. Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation.
    Biochemistry. 1979 Dec 11;18(25):5567-71 PMID: 518855
  51. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).
    N Engl J Med. 1980 Jun 5;302(23):1283-92 PMID: 6154243
  52. Speculations on the functions of the major heat shock and glucose-regulated proteins.
    Cell. 1986 Sep 26;46(7):959-61 PMID: 2944601
  53. Quasi-irreversibility in the unfolding-refolding transition of phosphoglycerate kinase induced by guanidine hydrochloride.
    Eur J Biochem. 1987 Feb 16;163(1):29-34 PMID: 3816800
  54. Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation. A model for inclusion body formation.
    J Biol Chem. 1988 Apr 5;263(10):4977-83 PMID: 2965152
  55. Mitochondrial heat-shock protein hsp60 is essential for assembly of proteins imported into yeast mitochondria.
    Nature. 1989 Feb 16;337(6208):620-5 PMID: 2645524
  56. Intermediates in the folding reactions of small proteins.
    Annu Rev Biochem. 1990;59:631-60 PMID: 2197986
  57. Chaperonin-mediated protein folding at the surface of groEL through a 'molten globule'-like intermediate.
    Nature. 1991 Jul 4;352(6330):36-42 PMID: 1676490
  58. Global suppression of protein folding defects and inclusion body formation.
    Science. 1991 Jul 5;253(5015):54-8 PMID: 1648264
  59. The mechanism of Z alpha 1-antitrypsin accumulation in the liver.
    Nature. 1992 Jun 18;357(6379):605-7 PMID: 1608473
  60. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.
    Biochemistry. 1992 Sep 15;31(36):8654-60 PMID: 1390650
  61. Temperature-sensitive mutations in the phage P22 coat protein which interfere with polypeptide chain folding.
    J Biol Chem. 1993 May 5;268(13):9358-68 PMID: 8486630
  62. Chaperonins can catalyse the reversal of early aggregation steps when a protein misfolds.
    J Mol Biol. 1995 Jul 28;250(5):581-6 PMID: 7623376
  63. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.
    Biochemistry. 1995 Oct 17;34(41):13527-36 PMID: 7577941
  64. Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates.
    FASEB J. 1996 Jan;10(1):57-66 PMID: 8566549
  65. 3D domain swapping: a mechanism for oligomer assembly.
    Protein Sci. 1995 Dec;4(12):2455-68 PMID: 8580836
  66. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Biochemistry. 1996 May 21;35(20):6470-82 PMID: 8639594
  67. Alternative conformations of amyloidogenic proteins govern their behavior.
    Curr Opin Struct Biol. 1996 Feb;6(1):11-7 PMID: 8696966
  68. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix.
    Structure. 1996 Aug 15;4(8):989-98 PMID: 8805583
  69. Inhibiting transthyretin amyloid fibril formation via protein stabilization.
    Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15051-6 PMID: 8986762
  70. From Levinthal to pathways to funnels.
    Nat Struct Biol. 1997 Jan;4(1):10-9 PMID: 8989315
  71. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
    Nature. 1997 Feb 27;385(6619):787-93 PMID: 9039909
  72. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae.
    Cell. 1997 May 30;89(5):811-9 PMID: 9182769
  73. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.
    Annu Rev Biochem. 1997;66:385-407 PMID: 9242912
  74. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.
    Cell. 1997 Aug 8;90(3):549-58 PMID: 9267034
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
DOI
10.1172/JCI16781
Email
horwich@csb.yale.edu
Published
2002-11-00
Pages
1221-32
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC151620
Subset
IM
External Links
PubMed source DOI: 10.1172/JCI16781 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2